These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3908219)

  • 41. Metabolic activation and deactivation of mutagens by preparations of human lung parenchyma and bronchial tree.
    De Flora S; Bennicelli C; Zanacchi P; Camoirano A; Petruzzelli S; Giuntini C
    Mutat Res; 1984 Jan; 139(1):9-14. PubMed ID: 6361547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigations on the mutagenicity of primary and secondary alpha-acetoxynitrosamines with Salmonella typhimurium: activation and deactivation of structurally related compounds by S-9.
    Pool BL; Wiessler M
    Carcinogenesis; 1981; 2(10):991-7. PubMed ID: 7028307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of the control of mutagenic metabolites derived from cyclophosphamide and ifosfamide by stimulation of protein kinase A.
    Oesch-Bartlomowicz B; Vogel S; Arens HJ; Oesch F
    Mutat Res; 1990 Oct; 232(2):305-12. PubMed ID: 2170835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of nicotinamide on mutagenic activity of N-nitrosomorpholine in the AMES/Salmonella microsome test.
    Braun R; Schöneich J; Ziebarth D
    Exp Pathol (Jena); 1980; 18(5):314-9. PubMed ID: 6447615
    [No Abstract]   [Full Text] [Related]  

  • 45. Role of glutathione in liver-mediated mutagenicity of acrylonitrile.
    Duverger-Van Bogaert M; Lambotte-Vandepaer M; de Meester C; Mercier M; Poncelet F
    Toxicol Lett; 1982 May; 11(3-4):305-11. PubMed ID: 7048631
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutagenic activity of cyclophosphamide, ifosfamide, and trofosfamide in different genes of escherichia coli and salmonella typhimurium after biotransformation through extracts of rodent liver.
    Ellenberger J; Mohn G
    Arch Toxicol; 1975; 33(3):225-40. PubMed ID: 1096853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High mutagenicity of N-(alpha-acyloxy)alkyl-N-alkylnitrosamines in S. typhimurium: model compounds for metabolically activated N,N-dialkylnitrosamines.
    Camus AM; Wiessler M; Malaveille C; Bartsch H
    Mutat Res; 1978 Feb; 49(2):187-94. PubMed ID: 342933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutagenicity and alpha-hydroxylation of N-nitrosopyrrolidine and N-nitrosopiperidine: a possible correlation.
    Gilbert PJ; Rollmann B; Rondelet J; Mercier M; Poncelet F
    Toxicology; 1981-1982; 22(4):345-52. PubMed ID: 7342373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolism of cyanoacrylic compounds: toxicity and detoxification. Identification of mercapturic acids and the role of glutathione conjugation in the biotransformation of cyanoacrylic acids.
    Rietveld EC
    Pharm Weekbl Sci; 1988 Oct; 10(5):224-5. PubMed ID: 3060837
    [No Abstract]   [Full Text] [Related]  

  • 50. Mutagenicity of nitrosodiethanolamine on Salmonella typhimurium.
    Hesbert A; Lemonnier M; Cavelier C
    Mutat Res; 1979 Nov; 68(3):207-10. PubMed ID: 117355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plant cells at different stages in their growth curve differentially activate promutagens.
    Gentile JM; Heydenburg D; Hertel L; Plewa MJ
    Mutat Res; 1987; 191(3-4):151-5. PubMed ID: 3306366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrahepatic mutagenesis assay: a sensitive method for detecting N-nitrosomorpholine and in vivo nitrosation of morpholine.
    Edwards G; Whong WZ; Speciner N
    Mutat Res; 1979 Dec; 64(6):415-23. PubMed ID: 392314
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activating and inactivating reactions controlling 2-naphthylamine mutagenicity.
    Bock-Hennig BS; Ullrich D; Bock KW
    Arch Toxicol; 1982 Sep; 50(3-4):259-66. PubMed ID: 7149991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of pH on mutagenesis by thiols in Salmonella typhimurium TA102.
    Stark AA; Arad A; Siskindovich S; Pagano DA; Zeiger E
    Mutat Res; 1989 Sep; 224(1):89-94. PubMed ID: 2671715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of Mesna (2-mercaptoethane sulfonate) with the mutagenicity of cyclophosphamide in vitro and in vivo.
    Lähdetie J; Räty R; Sorsa M
    Mutat Res; 1990 Sep; 245(1):27-32. PubMed ID: 2118231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutagenic activation of dialkylnitrosamines by intact urothelial cells.
    Moore CM; Goodall CM; Beagley KW; Stephens OB; Horne L; Noronha RF
    Mutat Res; 1985 Jul; 157(1):95-105. PubMed ID: 3892287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutagenicity of N-nitrosomorpholine biosynthesized from morpholine in the presence of nitrate and its inhibition by ascorbic acid.
    Pérez A; Fernández SI; Garcia-Roché MO; de las Cagigas A; Castillo A; Fonseca G; Herrera M
    Nahrung; 1990; 34(7):661-4. PubMed ID: 2089264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The mutagenic effect of 1,2-dichloroethane on Salmonella typhimurium I. Activation through conjugation with glutathion in vitro.
    Rannug U; Sundvall A; Ramel C
    Chem Biol Interact; 1978 Jan; 20(1):1-16. PubMed ID: 24503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characteristics of the activation of cyclophosphamide to a mutagen by rat liver.
    Hales BF; Jain R
    Biochem Pharmacol; 1980 Feb; 29(2):256-9. PubMed ID: 6767482
    [No Abstract]   [Full Text] [Related]  

  • 60. Studies on the metabolic activation of diethanolnitrosamine in animal-mediated and in vitro assays using Escherichia coli K-12 343/113 as an indicator.
    Knasmüller S; Stehlik G; Mohn G
    J Cancer Res Clin Oncol; 1986; 112(3):266-71. PubMed ID: 3536944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.